Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Martin Shkreli
MedTech
Shkreli wants back into biopharma with blockchain bet
Despite a judge banning the famous “pharma bro” from working in the drug industry for life, Martin Shkreli wants to get back in the mix.
Conor Hale
Jul 26, 2022 3:00pm
Retrophin sheds Shkreli connection with new name: Travere
Nov 17, 2020 10:30am
Retrophin buys up Orphan Technologies for rare disease drug
Oct 23, 2020 8:18am
Humanigen drug shows early promise in COVID-19
Jun 17, 2020 8:30am
From prison, Shkreli sues—and settles with—Retrophin executives
Jun 21, 2019 10:33am
Shkreli in the stocks; still sharing biotech tips
Jul 3, 2018 11:25am
